Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huatan Dingji Formula (also known as Huatan Dingji Decoction or HTDJ) is a traditional Chinese medicine (TCM) herbal formula developed at Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is designed for the treatment of atrial fibrillation (AF), specifically targeting the TCM syndrome pattern of qi deficiency and phlegm opacities (palpitation of qi deficiency-caused phlegm stagnation). The formula is composed of multiple herbal ingredients, including pinellia ginger, tangerine peel, astragalus root, atractylode rhizome, Poria, Coptis chinensis, cinnamon, keel, oyster, Radix ophiopogonis, Chinese date, Epimedium, and sophora flavescens. It is evaluated in clinical trials in combination with western basic therapy to reduce the frequency of palpitation, cumulative attack time, and improve clinical symptoms and quality of life in patients with paroxysmal or persistent atrial fibrillation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huatan Dingji Formula.